论文部分内容阅读
对３７５例孕妇进行了产前ＡＢＯ血型、Ｒｈ血型鉴定及血清学检查，结果母儿血型不合的免疫性抗体阳性８４例（２２．４％），２８例新生儿受累，占免疫抗体阳性者的３３．３％。经过恰当的产科处理及救治，除１例死于换血疗法并发症外，其余２７例全部存活，与既往未经监测与治疗的妊娠结局相比差异非常显著（Ｐ＜０．０１）。本文分析了ＡＢＯ母儿血型不合与血型分布的关系、免疫性抗体阳性率；阐述了孕期监测与治疗方案，强调婚前及产前初诊时血型鉴定的必要性。
Prenatal ABO blood group, Rh blood group identification and serological examination were performed on 375 pregnant women. The results showed that 84 cases (22.4%) were positive with incompatible maternal blood group, 28 cases were newborn, accounting for the immunocompetent positive 33.3%. After proper obstetric treatment and treatment, all the other 27 patients survived, except for one patient who died of blood transfusions. The difference was statistically significant (P <0.01) compared with the previous unmonitored and therapeutic pregnancy outcomes. This article analyzes the ABO mother and child blood group incompatible with the distribution of blood type, the positive rate of immune antibodies; described during pregnancy monitoring and treatment programs, emphasizing the need for prenatal and prenatal blood group identification.